Skip to main content
. 2025 Oct 9;112(1):110–120. doi: 10.1097/JS9.0000000000003591

Table 4.

Subgroup analysis based on lesion location, size, and morphology4

OR CI lower CI higher P value
Diagnostic inaccuracy vs. biospy method
 Head 0.438 0.158 1.209 0.140
 Uncinate process 0.878 0.312 2.469 1.00
 Neck 1.721 0.298 9.937 0.685
 Body 0.543 0.151 1.954 0.530
 Tail 2.791 0.721 10.801 0.215
 Exophytic and backward growth morphology 0.154 0.048 0.493 0.001
 Non-exophytic and backward growth morphology 1.616 0.847 3.083 0.151
 Tumor size < 2 cm 0.719 0.277 1.871 0.631
 Tumor size ≧ 2 cm 0.900 0.487 1.664 0.757
Repeat biopsy vs. biospy method
 Head 0.564 0.179 1.780 0.397
 Uncinate process 0.611 0.175 2.139 0.549
 Neck 1.429 0.319 6.396 0.724
 Body 0.644 0.173 2.402 0.744
 Tail 4.108 0.452 37.330 0.370
 Exophytic and backward growth morphology 0.312 0.111 0.879 0.029
 Non-exophytic and backward growth morphology 1.485 0.679 3.249 0.334
 Tumor size < 2 cm 0.435 0.146 1.302 0.192
 Tumor size ≧ 2 cm 1.133 0.555 2.313 0.856
4.

EUS: endoscopic ultrasound, US: ultrasound, PSM: propensity score matching, OR: odds ratio, CI: confidence interval.

The bold values in Table 4 indicate statistically significant results (p < 0.05). They are highlighted to emphasize the findings that met our predefined threshold for significance.